New Delhi: Citing quality issues, India's drug regulator Drug Controller General of India (DCGI) has banned the import of ingredients of drugs from six major Chinese pharmaceutical firms. The move, according to pharma lobby groups could have serious ramifications for the Indian pharma industry, even ...
Read more: DCGI bans import of drug ingredients from six Chinese firms